Literature DB >> 11739905

Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit.

H G Rincon1, M Granados, J Unutzer, M Gomez, R Duran, M Badiel, C Salas, J Martinez, J Mejia, C Ordoñez, N Florez, F Rosso, P Echeverri.   

Abstract

This study assesses the levels of depression, anxiety, and delirium during admission to three adult critical care units (CCU) and the performance of CCU staff with respect to detection and treatment. During a 1-month period, 96 consecutive patients were evaluated on the first day of admission by an independent rater, using the Hospital Anxiety Depression Scale and the Confusional Assessment Method. Frequency of alcohol use and demographic data were recorded. CCU teams rarely made diagnoses of anxiety, depression, or delirium. On at least one screening test, 29.2% of patients were positive. Delirium was present in 7.3%, depression in 13.7%, anxiety in 24%, and possible problem drinking in 37.9%. Although some form of psychiatric treatment was offered to 58%, there was low agreement between psychiatric diagnoses made by the independent rater and the diagnoses made and treatments used by CCU staff. This suggests that the CCU staff are using psychotropic medications without any clear documentation and perhaps clear understanding of the psychiatric diagnoses they are treating. In summary, we found high rates of psychiatric disorders in adult CCU patients but low rates of detection and only moderate rates of treatment by CCU staff.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739905     DOI: 10.1176/appi.psy.42.5.391

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  26 in total

Review 1.  Research issues in the evaluation of cognitive impairment in intensive care unit survivors.

Authors:  James C Jackson; Sharon M Gordon; E Wesley Ely; Candice Burger; Ramona O Hopkins
Journal:  Intensive Care Med       Date:  2004-09-15       Impact factor: 17.440

2.  Prescription Opioid Use Among Seriously Mentally Ill Veterans Nationally in the Veterans Health Administration.

Authors:  Nickie Mathew; Robert A Rosenheck
Journal:  Community Ment Health J       Date:  2015-09-15

Review 3.  Delirium and cognitive dysfunction in the intensive care unit.

Authors:  Russell R Miller; E Wesley Ely
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 5.285

4.  Psychiatric disorders and the ICU: gaps and opportunities.

Authors:  Christoph Pechlaner; Bruno Mégarbane; W Wolfgang Fleischhacker
Journal:  Intensive Care Med       Date:  2008-09-18       Impact factor: 17.440

5.  Do contact precautions cause depression? A two-year study at a tertiary care medical centre.

Authors:  H R Day; E N Perencevich; A D Harris; S S Himelhoch; C H Brown; A L Gruber-Baldini; E Dotter; D J Morgan
Journal:  J Hosp Infect       Date:  2011-06-12       Impact factor: 3.926

Review 6.  [Sleep disturbances in critically ill patients].

Authors:  B Walder; U Haase; I Rundshagen
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

7.  Incidence, risk factors and consequences of ICU delirium.

Authors:  Sébastien Ouimet; Brian P Kavanagh; Stewart B Gottfried; Yoanna Skrobik
Journal:  Intensive Care Med       Date:  2006-11-11       Impact factor: 17.440

8.  Depression, anxiety and alcohol abuse in a gastroenterology intensive care unit: prevalence and detection.

Authors:  Graça Cardoso; Joana Alexandre; Alda Rosa
Journal:  Clin Pract Epidemiol Ment Health       Date:  2010-07-08

9.  Recognition and treatment of depression and anxiety symptoms in heart failure.

Authors:  Jeffrey A Cully; Daniel E Jimenez; Tracey A Ledoux; Anita Deswal
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 10.  Recognition of depression by non-psychiatric physicians--a systematic literature review and meta-analysis.

Authors:  Monica Cepoiu; Jane McCusker; Martin G Cole; Maida Sewitch; Eric Belzile; Antonio Ciampi
Journal:  J Gen Intern Med       Date:  2007-10-26       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.